---
title: "Naloxone - Opioid-Related Disorders"
sidebar: mydoc_sidebar
permalink: db01183-mesh-d009293-1.html
toc: false 
---


Path ID: `DB01183_MESH_D009293_1`
{% include image.html url="images/db01183-mesh-d009293-1.png" file="db01183-mesh-d009293-1.png" alt="db01183-mesh-d009293-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D009270">MESH:D009270 </a> | Naloxone | Drug |
| <a href="https://identifiers.org/UniProt:P35372">UniProt:P35372 </a> | Mu-type opioid receptor | Protein |
| <a href="https://identifiers.org/UniProt:P41143">UniProt:P41143 </a> | Delta-type opioid receptor | Protein |
| <a href="https://identifiers.org/UniProt:P41145">UniProt:P41145 </a> | Kappa-type opioid receptor | Protein |
| <a href="https://identifiers.org/GO:0038003">GO:0038003 </a> | G protein-coupled opioid receptor signaling pathway | BiologicalProcess |
| <a href="https://identifiers.org/reactome:R-HSA-1296059">reactome:R-HSA-1296059 </a> | G protein gated Potassium channels | Pathway |
| <a href="https://identifiers.org/HP:0002791">HP:0002791 </a> | Hypoventilation | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D009293">MESH:D009293 </a> | Opioid-Related Disorders | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Naloxone | DECREASES ACTIVITY OF | Mu-Type Opioid Receptor |
| Naloxone | DECREASES ACTIVITY OF | Delta-Type Opioid Receptor |
| Naloxone | DECREASES ACTIVITY OF | Kappa-Type Opioid Receptor |
| Mu-Type Opioid Receptor | PARTICIPATES IN | G Protein-Coupled Opioid Receptor Signaling Pathway |
| Delta-Type Opioid Receptor | PARTICIPATES IN | G Protein-Coupled Opioid Receptor Signaling Pathway |
| Kappa-Type Opioid Receptor | PARTICIPATES IN | G Protein-Coupled Opioid Receptor Signaling Pathway |
| G Protein-Coupled Opioid Receptor Signaling Pathway | POSITIVELY REGULATES | G Protein Gated Potassium Channels |
| G Protein Gated Potassium Channels | CORRELATED WITH | Hypoventilation |
| Hypoventilation | POSITIVELY CORRELATED WITH | Opioid-Related Disorders |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01183#mechanism-of-action](https://go.drugbank.com/drugs/DB01183#mechanism-of-action)
  - [https://nida.nih.gov/publications/drugfacts/naloxone](https://nida.nih.gov/publications/drugfacts/naloxone)
  - [https://www.sciencedirect.com/topics/neuroscience/naloxone](https://www.sciencedirect.com/topics/neuroscience/naloxone)
  - [https://www.uniprot.org/uniprot/P35372#function](https://www.uniprot.org/uniprot/P35372#function)
  - [https://www.uniprot.org/uniprot/P41143#function](https://www.uniprot.org/uniprot/P41143#function)
  - [https://www.uniprot.org/uniprot/P41145#function](https://www.uniprot.org/uniprot/P41145#function)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755838/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755838/)
  - [https://en.wikipedia.org/wiki/Opioid_receptor#Mechanism_of_activation](https://en.wikipedia.org/wiki/Opioid_receptor#Mechanism_of_activation)
  - [https://en.wikipedia.org/wiki/Opioid_use_disorder](https://en.wikipedia.org/wiki/Opioid_use_disorder)
